VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RXRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RXRXRecursion Pharmaceuticals, Inc.
$3.80$1.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRXRXQuarterly Financials

Recursion Pharmaceuticals, Inc. (RXRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Recursion Pharmaceuticals, Inc. (RXRX) quarterly income statement — complete revenue, gross profit & net income history

RXRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue6.47M35.54M5.17M19.1M14.74M4.51M26.08M14.4M13.49M10.62M10.1M11.02M12.13M13.68M13.05M7.65M5.3M2.5M2.5M2.5M
Revenue Growth %-56.11%687.81%-80.16%32.62%9.3%-57.54%158.19%30.76%11.18%-22.32%-22.61%43.94%128.99%447.04%422.12%206.12%111.96%-2%--
Cost of Goods Sold12.49M26.88M29.59M20.16M21.83M12.79M12.08M9.2M11.17M9.88M10.88M9.38M12.45M10.84M15.41M14.23M7.8M000
COGS % of Revenue192.99%75.63%571.85%105.54%148.04%283.62%46.31%63.86%82.77%93.01%107.67%85.17%102.59%79.26%118.05%185.9%147.18%---
Gross Profit-6.02M8.66M-24.42M-1.06M-7.08M-8.28M14M5.21M2.33M743K-775K1.63M-314K2.84M-2.36M-6.57M-2.5M2.5M2.5M2.5M
Gross Margin %-92.99%24.37%-471.85%-5.54%-48.04%-183.62%53.69%36.14%17.23%6.99%-7.67%14.83%-2.59%20.74%-18.05%-85.9%-47.18%100%100%100%
Gross Profit Growth %15.05%204.58%-274.38%-120.33%-404.69%-1214.8%1906.84%218.54%840.45%-73.8%67.11%124.86%87.44%13.44%-194.24%-362.96%-200%-2%--
Operating Expenses122.49M117M147.78M175.17M184.28M175.49M112.36M105.75M98.67M99.67M98.78M83.35M69.55M63.82M60.22M59.62M53.48M67.46M48.9M43.43M
OpEx % of Revenue1892.57%329.21%2855.73%916.97%1249.81%3890.16%430.78%734.16%731.34%938.19%977.78%756.62%573.19%466.64%461.33%779%1009.27%2698.4%1956.08%1737.16%
Selling, General & Admin34.59M33.66M41.63M46.65M54.65M77.19M37.76M31.83M31.41M30.46M29.2M28.29M22.87M19.84M19.49M21.2M21.07M19.2M15.69M13.85M
SG&A % of Revenue534.47%94.71%804.41%244.22%370.63%1711.06%144.76%221%232.81%286.69%289.04%256.81%188.51%145.06%149.3%277%397.7%768.04%627.6%554.16%
Research & Development87.9M83.34M121.06M128.64M129.63M98.33M74.6M73.93M67.56M69.48M70.01M55.06M46.68M43.98M40.84M38.44M32.44M48.29M33.25M29.62M
R&D % of Revenue1358.1%234.51%2339.36%673.38%879.17%2179.87%286.02%513.25%500.78%654.01%693%499.82%384.68%321.59%312.85%502.27%612.21%1931.68%1329.84%1184.96%
Other Operating Expenses00-1000K-120K0-35K0-13K-303K-267K-431K-1K00-107K-21K-34K-33K-34K-49K
Operating Income-128.5M-108.33M-172.2M-176.23M-191.37M-183.77M-98.35M-100.54M-96.34M-98.93M-99.55M-81.72M-69.86M-60.98M-62.57M-66.19M-55.98M-64.96M-46.4M-40.93M
Operating Margin %-1985.55%-304.84%-3327.57%-922.51%-1297.85%-4073.78%-377.1%-698.02%-714.11%-931.19%-985.45%-741.78%-575.78%-445.91%-479.38%-864.9%-1056.44%-2598.4%-1856.08%-1637.16%
Operating Income Growth %32.85%41.05%-75.08%-75.28%-98.64%-85.76%1.2%-23.04%-37.89%-62.23%-59.09%-23.45%-24.8%6.12%-34.85%-61.72%-83.64%-153.94%--
EBITDA-108.83M-88.86M-151.16M-152.38M-172.04M-170.82M-91.16M-91.58M-88.96M-91.38M-91.97M-76.17M-66.14M-57.77M-59.58M-63.41M-53.21M-62.38M-43.97M-38.6M
EBITDA Margin %-1681.58%-250.03%-2920.95%-797.67%-1166.75%-3786.68%-349.5%-635.76%-659.42%-860.1%-910.43%-691.47%-545.06%-422.4%-456.48%-828.5%-1004.23%-2495.36%-1758.64%-1543.92%
EBITDA Growth %36.74%47.98%-65.82%-66.4%-93.38%-86.94%0.89%-20.22%-34.51%-58.18%-54.36%-20.14%-24.29%7.4%-35.52%-64.27%-82.98%-160.4%--
D&A (Non-Cash Add-back)19.67M19.48M21.04M23.85M19.33M12.95M7.2M8.97M7.38M7.55M7.58M5.54M3.73M3.21M2.99M2.79M2.77M2.58M2.44M2.33M
EBIT-128.5M-108.1M-162.25M-171.42M-202.14M-178.29M-95.12M-97.67M-92.13M-97.03M-92.99M-76.7M-65.31M-57.48M-60.43M-65.55M-55.97M-64.95M-47.21M-40.9M
Net Interest Income5.61M6.25M4.71M4.96M5.05M4.01M3.27M2.87M4.03M4.5M4.95M4.93M4.64M3.67M1.82M638K73K-2K-170K-2.47M
Interest Income5.96M6.25M5.54M5.44M5.05M4.62M3.83M3.27M4.05M4.52M4.98M4.96M4.66M3.68M1.83M652K87K050K29K
Interest Expense350K0833K480K0605K553K394K20K26K25K26K19K13K13K14K14K2K220K2.5M
Other Income/Expense6.4M232K9.95M4.33M-11.28M4.87M2.68M2.48M4.19M1.87M6.53M4.99M4.54M3.49M2.13M631K2K27K-1.03M-2.47M
Pretax Income-122.11M-108.1M-162.25M-171.9M-202.65M-178.9M-95.67M-98.06M-92.15M-97.06M-93.02M-76.73M-65.33M-57.49M-60.45M-65.56M-55.98M-64.93M-47.43M-43.4M
Pretax Margin %-1886.71%-304.19%-3135.27%-899.84%-1374.33%-3965.84%-366.82%-680.8%-683.06%-913.57%-920.78%-696.51%-538.38%-420.39%-463.07%-856.66%-1056.41%-2597.32%-1897.12%-1736.04%
Income Tax-4.6M20K3K0-158K7K167K-523K-779K-4.06M0000000000
Effective Tax Rate %3.77%-0.02%-0%0%0.08%-0%-0.17%0.53%0.85%4.19%0%0%0%0%0%0%0%0%0%0%
Net Income-117.5M-108.12M-162.25M-171.9M-202.49M-178.91M-95.67M-97.54M-91.37M-93M-93.02M-76.73M-65.33M-57.49M-60.45M-65.56M-55.98M-64.93M-47.43M-43.4M
Net Margin %-1815.57%-304.25%-3135.32%-899.84%-1373.26%-3965.99%-366.82%-677.17%-677.29%-875.34%-920.78%-696.5%-538.38%-420.39%-463.07%-856.66%-1056.41%-2597.32%-1897.12%-1736.04%
Net Income Growth %41.97%39.56%-69.59%-76.23%-121.6%-92.38%-2.86%-27.13%-39.87%-61.75%-53.89%-17.03%-16.7%11.46%-27.45%-51.06%-82.24%-152.01%--
Net Income (Continuing)-117.5M-108.12M-162.25M-171.9M-202.49M-178.91M-95.84M-97.54M-91.37M-93M-93.02M-76.73M-65.33M-57.49M-60.45M-65.56M-55.98M-64.93M-47.43M-43.4M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.22-0.21-0.36-0.41-0.50-0.53-0.34-0.40-0.39-0.40-0.43-0.38-0.32-0.31-0.34-0.38-0.33-0.38-0.28-0.26
EPS Growth %56%60.38%-5.88%-2.5%-28.21%-32.5%20.93%-5.26%-21.88%-29.03%-26.47%0%3.03%18.42%-21.43%-47.46%-80.82%-153.33%--
EPS (Basic)-0.22-0.21-0.36-0.41-0.50-0.53-0.34-0.40-0.39-0.40-0.43-0.38-0.32-0.31-0.34-0.38-0.33-0.38-0.28-0.26
Diluted Shares Outstanding529.3M526.72M446.99M417.36M402.77M336.04M282.58M242.2M236.02M233.16M214.33M201.42M191.62M185.67M173.44M172.21M170.69M169.37M168.53M168.43M
Basic Shares Outstanding529.3M526.72M446.99M417.36M402.77M336.04M282.58M242.2M236.02M233.16M214.33M201.42M191.62M185.67M173.44M172.21M170.69M169.37M168.53M168.43M
Dividend Payout Ratio--------------------